Rankings
▼
Calendar
MNKD Q2 2024 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$72M
+48.9% YoY
Gross Profit
$52M
71.8% margin
Operating Income
$17M
22.9% margin
Net Income
-$2M
-2.8% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+9.2%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$861,000
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$444M
Total Liabilities
$670M
Stockholders' Equity
-$226M
Cash & Equivalents
$97M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$72M
$49M
+48.9%
Gross Profit
$52M
$34M
+51.3%
Operating Income
$17M
$2M
+865.1%
Net Income
-$2M
-$5M
+61.7%
Revenue Segments
License And Service
$26M
36%
Royalty
$26M
35%
Product
$21M
29%
← FY 2024
All Quarters
Q3 2024 →